Sensex, Nifty Decline For Third Straight Session; Energy Shares Weigh
The S&P BSE Sensex and NSE Nifty 50 indexes fell for third session in a row on Tuesday weighed down by weakness in energy, pharma and auto shares. For most part of the day, benchmarks traded in a choppy fashion and switched directions more than five times during the session before closing in the negative territory. The Sensex fell as much as 143 points and the NSE Nifty 50 index dropped below important psychological level of 11,800. Reliance Industries, HDFC Bank, Larsen & Toubro, HCL Technologies and Sun Pharma were among the biggest drags on the Sensex.
The Sensex closed 82 points or 0.2 per cent lower at 40,281 and the Nifty 50 index fell 32 points or 0.3 per cent to settle at 11,798.
In the last three trading sessions, the Sensex has shed 2.5 per cent and the NSE Nifty 50 index has slumped 2.7 per cent.
Fourteen of 19 sector gauges compiled by BSE ended lower led by the S&P BSE Energy index's 1.6 per cent fall. S&P BSE Healthcare, Consumer Durables, Oil & Gas and Auto indexes also fell between 1-1.2 per cent each.
On the other hand, S&P BSE Realty index was top gainer, up 1 per cent.
Mid- and small-cap shares also witnessed a mild selling pressure. The S&P BSE MidCap and S&P BSE SmallCap indexes declined 0.4 per cent each.
Sun Pharma was top loser in the Sensex, the stock fell 2.4 per cent to close at Rs 389.
HCL Technologies, Reliance Industries, IndusInd Bank, Larsen & Toubro, Titan, UltraTech Cement, Bajaj Auto, Maruti Suzuki, HDFC Bank and Mahindra & Mahindra were also among the losers.
On the flipside, TCS was top Sensex gainer, up 2 per cent to settle at Rs 2,158. Tata Steel, Bharti Airtel, State Bank of India, Hindustan Unilever and Tech Mahindra were also among the gainers.
The overall market breadth was negative as 1,477 shares closed lower while 959 ended higher on the BSE.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.